Rapid reversal of renal failure after initiation of HAART: A case report

AIDS Reader

Volumn 14, Issue 8, 2004, Pages 443-447

  Scheurer, Danielle ^a  

^a Dept Int Med Med U S Carolina ^*  (United States)

Author keywords

Antiretroviral therapy; End stage renal failure; HIV AIDS; Nephropathy

Indexed keywords

ANTIRETROVIRUS AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; MALE; PROTEINURIA; REMISSION;

AIDS-ASSOCIATED NEPHROPATHY; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HUMANS; MALE; MIDDLE AGED;

EID: 3943060882     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Weiner NJ, Goodman JW, Kimmel PL. The HIV-associated renal diseases: current insight into pathogenesis and treatment. Kidney Int. 2003;63:1618-1631.
2. Winston JA, Klotman PE. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int. 1999;55:1036-1040.
3. Winston JA, Bruggeman LA, Ross MD, et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med. 2001;344:1979-1984.
4. Ahuja TS, Borucki M, Funtanilla M, et al. Is the prevalence of HIV-associated nephropathy decreasing? Am J Nephrol. 1999;19:655-659.
5. Shahinian V, Rajaraman S, Borucki M, et al. Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients. Am J Kidney Dis. 2000;35:884-888.
6. Cantor ES, Kimmel PI, Bosch JP. Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy. Arch Intern Med. 1991;151:125-128.
7. Kopp JB, Winkler C. HIV-associated nephropathy in African Americans. Kidney Int. 2003;63:S43-S49.
8. Smith MC, Austen JL, Carey JT, et al. Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy. Am J Med. 1996;101:41-48.
9. Eustace JA, Nuermberger E, Choi M, et al. Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids. Kidney Int. 2000; 58:1253-1260.
10. Laradi A, Mallet A, Beaufils H, et al. HIV-associated nephropathy: outcome and prognosis factors. Groupe d' Etudes Nephrologiques d'Ile de France. J Am Soc Nephrol. 1998;9:2327-2335.
11. Szczech LA, Edwards LJ, Sanders LL, et al. Protease inhibitors are associated with a slowed progression of HIV-related renal diseases. Clin Nephrol. 2002;57:336-341.
12. Burns GC, Paul SK, Toth IR, Sivak SL. Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy. J Am Soc Nephrol. 1997;8:1140-1146.
13. Kimmel PL, Mishkin GJ, Umana WO. Captopril and renal survival in patients with human immunodeficiency virus nephropathy. Am J Kidney Dis. 1996;28:202-208.
14. Ifudu O, Rao TK, Tan CC, et al. Zidovudine is beneficial in human immunodeficiency virus associated nephropathy. Am J Nephrol. 1995;15:217-221.
15. Michel C, Dosquet P, Ronco P, et al. Nephropathy associated with infection by human immunodeficiency virus: a report on 11 cases including 6 treated with zidovudine. Nephron. 1992;62:434-440.
16. Abbott KC, Hypolite I, Welch PG, Agodoa LY. Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era. J Nephrol. 2001;14:377-383.
17. Wali RK, Drachenberg CI, Papadimitriou JC, et al. HIV-1-associated nephropathy and response to highly-active antiretroviral therapy. Lancet. 1998;352:783-784.
18. Kirchner JT. Resolution of renal failure after initiation of HAART: 3 cases and a discussion of the literature. AIDS Reader. 2002;12:103-105, 110-112.
19. Morales E, Martinez A, Sanchez-Ayuso J, et al. Spontaneous improvement of the renal function in a patient with HIV-associated focal glomerulosclerosis. Am J Nephrol. 2002;22:369-371.